Piper Sandler raises its price target on KORU Medical Systems (NASDAQ:KRMD) to $3.00

KORU Medical Systems (NASDAQ:KRMD – Free Report) Their price target was boosted by Piper Sandler from $2.50 to $3.00 in a research note on Thursday, Benzinga reports. The firm currently has an overweight rating on the stock.

Separately, B. Riley assumed coverage on shares of KORU Medical Systems in a report on Thursday, July 25th. They issued a buy rating and a $4.00 target price on the stock.

Check out the latest stock analysis on KRMD

KORU Medical Systems stock performance

Shares of KRMD stock opened at $2.54 on Thursday. The company’s 50-day moving average is $2.44 and its 200-day moving average is $2.28. The stock has a market cap of $116.23 million, a P/E ratio of -9.07 and a beta of 0.40. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $3.12. The company has a current ratio of 4.01, a quick ratio of 3.37, and a debt-to-equity ratio of 0.02.

KORU Medical Systems (NASDAQ:KRMD – Get Your Free Report ) last announced its quarterly earnings results on Wednesday, August 7th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. KORU Medical Systems had a negative return on equity of 25.10% and a negative net margin of 45.24%. The company had revenue of $8.43 million during the quarter, compared to analysts’ expectations of $7.52 million. During the same period in the previous year, the company earned ($0.05) earnings per share. On average, sell-side analysts anticipate that KORU Medical Systems will post -0.16 earnings per share for the current year.

Institutional inputs and outputs

Several institutional investors have recently added to or reduced their stakes in KRMD. Allspring Global Investments Holdings LLC bought a new stake in KORU Medical Systems during the 2nd quarter valued at about $28,000. Aaron Wealth Advisors LLC purchased a new position in shares of KORU Medical Systems in the second quarter valued at approximately $28,000. Mesirow Financial Investment Management Inc. bought a new stake in shares of KORU Medical Systems in the first quarter valued at approximately $26,000. Legato Capital Management LLC purchased a new stake in KORU Medical Systems in the second quarter valued at $35,000. Finally, Advisor Resource Council bought a new position in KORU Medical Systems in the 1st quarter worth $63,000. 58.60% of shares are currently owned by institutional investors.

KORU Medical Systems Company Profile

(Get a free report)

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It provides free infusion systems to provide lifesaving therapies to patients with chronic diseases such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.

See Also

Receive daily news and reviews for KORU Medical Systems – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for KORU Medical Systems and related companies with MarketBeat.com’s FREE daily email newsletter.